Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca CEO Says Post-Crestor Future On Track As Pipeline Builds

Jul 28 2016

• By Sten Stovall

Pascal Soriot — AstraZeneca CEO Pascal Soriot • Source: AstraZeneca

Related Content

Crestor Generics To Launch After 12-Day Delay

Jul 21 2016

AstraZeneca Faces 'Key Pressures' But $45bn Sales Target 'Still Achievable'

Feb 04 2016

AstraZeneca's 'Clear-Out' Strategy Sees Gout Drug Go To Grunenthal

Jun 02 2016

AstraZeneca BD Head Says More Out-Licensing, Divestment Expected In 2016

Apr 12 2016

AstraZeneca rebuffs Pfizer approach, report claims

Apr 21 2014

UK Pharma Chiefs To Helm Brexit Steering Committee

Jul 10 2016

Generic Crestor Marks The End Of An Era, Should Quickly Outperform PCSK9s

May 02 2016

Related Companies

AstraZeneca PLC

Kyowa Kirin Co., Ltd.

ProStrakan Group plc

Pfizer Inc.

Additional Topics

United Kingdom Europe Brexit Business Strategies Companies Commercial Cancer Immune Disorders Metabolic Disorders Cardiovascular BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window